Novel Targets in Advanced Colorectal Cancer

被引：1

作者：

Lee, Joycelyn Jie Xin ^{[1
]}

Choo, Su Pin ^{[1
]}

Chua, Clarinda ^{[1
]}

机构：

[1] Natl Canc Ctr Singapore, Div Med Oncol, 11 Hosp Dr, Singapore 169610, Singapore

来源：

CURRENT COLORECTAL CANCER REPORTS | 2018年 / 14卷 / 06期

关键词：

Colon cancer; Rectal cancer; Targeted therapy; Oncogenic gene fusions; Immunotherapy; Microbiome;

D O I：

10.1007/s11888-018-0422-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Purpose of ReviewAlthough current guidelines suggest only testing for RAS and BRAF mutations as well as MMR deficiency in metastatic colon cancer, there are many other promising therapeutic targets that are being studied. We aim to review the recent literature and evidence behind some of these novel targets.Recent FindingsMany of these targets such as NTRK, ROS, ALK, and HER2 are being studied in current clinical trials and hold great potential in changing the treatment landscape for metastatic colorectal cancer.SummaryCurrent molecular testing algorithms may need to be expanded to allow better target discovery and for patients to benefit from more therapeutic options.

引用

页码：192 / 198

页数：7

共 50 条

[21] Copy Number Alterations as Novel Biomarkers and Therapeutic Targets in Colorectal Cancer
Tan, Elaine S.
Knepper, Todd C.
Wang, Xuefeng
Permuth, Jennifer B.
Wang, Liang
Fleming, Jason B.
Xie, Hao
CANCERS, 2022, 14 (09)
[22] A novel low-toxicity regimen for advanced colorectal cancer?
Yoko Yanagisawa
Rachel S. Midgley
Nature Reviews Clinical Oncology, 2010, 7 : 556 - 557
[23] A novel low-toxicity regimen for advanced colorectal cancer?
Yanagisawa, Yoko
Midgley, Rachel S.
NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (10) : 556 - 557
[24] Novel Targets in Advanced Non-Small Cell Lung Cancer
Liu, Stephen, V
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (07) : 426 - 429
[25] New molecular targets and novel agents in the treatment of advanced urothelial cancer
Beekman, Kathleen W.
Bradley, Deborah
Hussain, Maha
SEMINARS IN ONCOLOGY, 2007, 34 (02) : 154 - 164
[26] TAM receptors Tyro3 and Mer as novel targets in colorectal cancer
Schmitz, Robin
Valls, Aida Freire
Yerbes, Rosario
von Richter, Sophie
Kahlert, Christoph
Loges, Sonja
Weitz, Jurgen
Schneider, Martin
de Almodovar, Carmen Ruiz
Ulrich, Alexis
Schmidt, Thomas
ONCOTARGET, 2016, 7 (35) : 56355 - 56370
[27] Prognosis and Novel Drug Targets for Key lncRNAs of Epigenetic Modification in Colorectal Cancer
Zhang, Peng
Zhang, Tingting
Chen, Denggang
Gong, Li
Sun, Min
MEDIATORS OF INFLAMMATION, 2023, 2023
[28] MYOFERLIN: A NOVEL PREDICTIVE BIOMARKER AND THERAPEUTIC TARGET IN ADVANCED COLORECTAL CANCER
Fowler, H.
Sutton, P.
Bowden, D.
Parsons, J.
Vimalachandran, D.
BRITISH JOURNAL OF SURGERY, 2021, 108 : 23 - 23
[29] New targets in metastatic colorectal cancer
Ulrich-Pur H.
memo - Magazine of European Medical Oncology, 2015, 8 (2) : 101 - 104
[30] Molecular targets for prevention of colorectal cancer
不详
TOXICOLOGIC PATHOLOGY, 2005, 33 (07) : 821 - 821

← 1 2 3 4 5 →